Increasing Pet Ownership Sparks Demand for Dog Vaccines Market
Dog Vaccines
are used to prevent various infectious diseases in pet dogs such as parvovirus,
distemper, hepatitis etc. Growing pet ownership especially dog ownership is
fueling the demand for Dog Vaccines worldwide.
The Global Dogs
Vaccines Market is estimated to be valued at USD 2.21 Bn in 2025 and is
expected to reach USD 3.52
Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032
Dog Vaccines help in controlling the spread of infectious
diseases and enhancing the overall immunity of pet dogs. Some of the key
players manufacturing Dog Vaccines are Merck & Co., Zoetis, Bayer Healthcare
etc. which provide a wide range of vaccines for dogs.
Key Takeaways
Key players operating in the Dog Vaccines Market are Merck & Co., Zoetis,
Bayer Healthcare, Virbac. Secondly, growing trend of nuclear families and
rising income levels have led to significant increase in adoption of pet dogs
worldwide which is driving the demand for dogs vaccines. Technological
advancements are also being made in vaccines whereby vaccine combinations are
being launched which protects against multiple diseases with a single dose.
Market Trends
One of the key witnessed in the Dog
Vaccines Market Trend is the growing popularity of veterinary biologics
such as recombinant vaccines. Recombinant pet vaccines offer advantages such as
purity and consistency over traditional vaccines. Another major trend is the
introduction of thermostable pet vaccines which do not require cold chain
management and offer convenience during transportation and storage.
Market Opportunities
Increasing focus of manufacturers on developing innovative vaccines for new
bacterial and viral diseases in pets presents significant growth opportunities.
For instance, vaccine development is currently ongoing for diseases such as
leptospirosis in dogs. Further, expansion in pets specialty retailing and
e-commerce channels for pets products will further aid the market growth of Dog
Vaccines during the forecast period.
Impact of COVID-19 on Dog Vaccines Market
The COVID-19 pandemic resulted in lockdowns and movement restrictions
worldwide. This led to challenges in the Dog Vaccines Market in terms of supply
chain disruptions and delays in routine vaccination programs. Sheltering at
home resulted in rise in pet adoption. However, many veterinary clinics were
temporarily closed or offered only emergency services during the peak of the
pandemic. This impacted the regular vaccination schedules. Telehealth
consultations saw growth as people sought to maintain their pets health while
avoiding clinics.
As restrictions ease and vaccinations against COVID-19 rollout, the market is
recovering. Pet owners are now catching up on delayed routine jabs. Demand is
also driven by the large pet owning population seeking to protect pets as they
spend more time at home. Manufacturers faced initial hiccups but have augmented
production capacities. Digital solutions and home delivery options are being
leveraged to ensure pets continue receiving necessary vaccines. The outbreak
has highlighted the importance of pet health and preventive care. If handled
well, the post-COVID scenario can see higher compliance rates for vaccination
programs.
North America holds the major share of the Dog Vaccines Market, both in terms
of value and volume. This is attributed to factors such as high pet owning
population, growing expenditure on animal health, and awareness about
preventive pet care. Asia Pacific is projected to be the fastest growing region
during the forecast period. Increasing pet adoption coupled with rising per
capita incomes is driving demand. Focus on strengthening veterinary
infrastructure and guidelines will support the market growth in the region.
Overall, recovery from the pandemic coupled with continued investments makes
for an optimistic long term outlook.
The Dog Vaccines Market in the US leads in terms of value. Key factors
contributing include high per capita pet healthcare expenditure, availability
of advanced products and well-established distribution channels. US Centers for
Disease Control and Prevention (CDC) estimate around 77 million dogs owned in
the country. Regular vaccination has become a imperative part of responsible
pet ownership. Large number of veterinary practitioners and comprehensive
guidelines foster market growth. While the region faced initial COVID-19
disruptions, it should rebound faster given economic recovery underway.
Get More
Insights On-Dog
Vaccines Market
About Author:
Ravina Pandya Content
Writer, has a strong foothold in the market research industry. She specializes
in writing well-researched articles from different industries, including food
and beverages, information and technology, healthcare, chemical and materials,
etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
